Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Am J Prev Med. 2016 Mar 30;51(1):33–45. doi: 10.1016/j.amepre.2016.01.029

Table 1.

Sample Sociodemographic Characteristics by Chronic Condition Status

Total Any condition No condition p-value
Total N (unweighted) 2,719 1,701 1,018
Total % (weighted) 64.3% 35.7%
Mean age at diagnosis (SD) - 9.93 (5.13) - -
Child’s age in 1997 (SD) 7.25 (3.30) 7.39 (3.17) 6.98 (3.52) 0.019
Sex 0.001
 Male 49.9% 52.7% 44.8%
 Female 50.1% 47.3% 55.2%
Race/Ethnicity 0.121
 White, non-Hispanic 57.7% 58.6% 56.1%
 Black, non-Hispanic 14.9% 14.3% 15.9%
 Asian, non-Hispanic 3.2% 2.6% 4.4%
 Other, non-Hispanic 6.9% 7.7% 5.4%
 Hispanic 17.3% 16.8% 18.2%
Prenatal WIC/AFDC participation 0.023
 Yes 30.6% 32.5% 27.1%
 No 69.4% 67.5% 72.9%
Parent’s marital status in 1997 0.047
 Two parent household 76.9% 75.5% 79.6%
 Single parent household 23.1% 24.5% 20.4%
Parental education 0.325
 Less than high school 12.6% 11.6% 14.6%
 High school degree 24.8% 24.9% 24.5%
 Some college 22.0% 22.3% 21.5%
 College grad or more 40.6% 41.2% 39.3%
Psychological distress (SD) 4.55 (2.73) 4.88 (2.76) 3.96 (2.54) <0.0001
Substance use
Lifetime use of any substance 74.7% 77.0% 70.5% 0.004
 Use of one substance 21.6% 21.0% 22.6%
 Use of two substances 20.0% 20.7% 18.7% 0.014
 Use of three substances 33.1% 35.3% 29.2%
Heavier use of any substance 47.7% 51.7% 40.4% <0.001
 Heavier use of one substance 20.4% 21.2% 19.1%
 Heavier use of two substances 16.6% 17.8% 14.4% <0.001
 Heavier use of three substances 10.7% 12.8% 6.9%
Mean age of initiation (SD)
 Any alcohol use 17.49 (3.51) 17.99 (3.33) 16.80 (3.65) <0.001
 Any tobacco use 15.73 (2.69) 15.88 (2.62) 15.54 (2.76) 0.073
 Any marijuana use 15.32 (2.73) 15.39 (2.67) 15.24 (2.79) 0.386
a

Unweighted Ns and weighted percentages and means (SDs) are presented.

b

Chronic conditions include: attention deficit/hyperactivity disorder; asthma; autism; birth defects; breathing problems; cancer; chronic hypertension; diabetes; digestive problems; emotional or psychological problems; epilepsy; heart conditions; kidney disease; learning disability or developmental delays; migraines; orthopedic conditions; sickle cell anemia; skin disease; hearing, speech, or visual impairments; and other conditions.

c

WID/AFDC - Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and Aid to Families with Dependent Children (AFDC) programs

d

Mean Kessler 6 score from administrations during ages 12–26. Higher scores indicate more distress.

e

Data are from the Panel Study of Income Dynamics, Child Development and Transition to Adulthood Supplements (2002–2011).